Arine vs FeelBetter
Both find the patients whose medication list has become the problem, and they sell that to different buyers with different economics behind it. Arine sells medication intelligence to health plans, working across a membership and reporting savings per engaged member, with a HITRUST risk based certification that is the most demanding tier of that programme and the strongest security posture in this part of the category. FeelBetter targets polypharmacy in older adults specifically, stratifying by risk of near term deterioration or hospitalisation, and has peer reviewed work behind it, though the published study measured something narrower than the company's marketing claims. If you are a plan, Arine is built for your data and your contracting. If you are a provider group or a pharmacy service managing complex elderly patients, FeelBetter is aimed at the clinical problem rather than at the medical loss ratio.
- The buyer and the workflow are payer side, ingesting clinical, socioeconomic and behavioural data across a plan's membership to find members at risk before an event rather than reviewing a hospital's inpatients.
- HITRUST risk based two year certification, attained in 2024, is the most demanding tier of that programme and the strongest security position in this part of the category.
- Results are named to real clients with quantified savings per engaged member, which is more commercial specificity than most vendors here provide even though it is self reported.
- The population is the sharper target: older adults on enough medications that the regimen itself is the hazard, stratified by risk of near term deterioration or hospitalisation rather than by generic medication burden.
- There is peer reviewed work behind it, and the useful part is the gap between what the study measured and what the company claims, which a buyer can read and judge for themselves.
- The oversight chain is conventional and sound, with recommendations reaching a clinical pharmacist and any change still requiring a prescriber.
Side by Side
| Axis | A Arine |
F FeelBetter |
|---|---|---|
| AI Centrality | ||
| Autonomy and Oversight Model | ||
| Model and Technology Transparency | ||
| Clinical and Operational Evidence | ||
| AI Safety and PHI Stewardship | ||
| HIPAA and BAA Posture | ||
| Security Certifications and Trust Center | ||
| FDA and Regulatory Status | ||
| AI Governance and Bias Disclosure | ||
| EHR and Interoperability Depth | ||
| Deployment Model and Data Residency | ||
| Commercial Transparency | ||
| Setting and Specialty Coverage |
Related comparisons
Other published head to head assessments involving these vendors or their closest peers. The full set for this category is on the Clinical Decision Support page.
Both vendors sell outcomes that are measured by the party being paid for them. Arine's savings figures above a stated amount per engaged member are entirely self reported, and FeelBetter presents impact metrics as labelled categories rather than as a study, so ask both for the denominator, the comparison group and who computed the result.
FeelBetter publishes no located HIPAA statement, business associate terms, security attestation or trust centre, and no subgroup performance or bias assessment, which is a wide gap for a product stratifying an elderly population. Neither publishes pricing.